Humanin 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Humanin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF112025093

Key analytical results include:

• Assay Content: 10.44 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 996
• Purity: 99.3 percent
• Bacterial Endotoxins: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Humanin is a mitochondrial-derived peptide studied in controlled laboratory environments investigating cellular signalling, mitochondrial biology and metabolic regulatory pathways.

The peptide belongs to a class of small mitochondrial signalling molecules that participate in intracellular communication between mitochondrial and nuclear regulatory systems.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Due to its defined peptide structure and stable analytical profile, Humanin has become a frequently referenced molecule in experimental models studying mitochondrial signalling and cellular stress response pathways.

Compound Overview

Humanin is a short mitochondrial-derived peptide originally identified during studies investigating mitochondrial genetic expression and intracellular signalling molecules.

Within biochemical research models, Humanin is commonly examined for its involvement in mitochondrial signalling pathways and cellular stress response mechanisms.

The peptide has been investigated in experimental systems analysing mitochondrial–nuclear communication and intracellular regulatory networks.

These research models allow scientists to explore peptide-mediated signalling processes involved in cellular metabolism and mitochondrial regulatory systems.

Historical Background and Scientific Context

Humanin was first identified in the early 2000s during investigations into mitochondrial-derived peptides and their potential role in cellular signalling.

The discovery contributed to a growing scientific understanding that mitochondria produce signalling peptides capable of influencing intracellular regulatory pathways.

Subsequent research expanded the study of mitochondrial-derived peptides, with Humanin becoming one of the most widely examined molecules within this emerging field.

Today the peptide is commonly used in laboratory research exploring mitochondrial signalling networks, metabolic regulation and intracellular communication pathways.

Mechanistic Focus in Research

Within experimental laboratory environments, Humanin is frequently studied in relation to mitochondrial signalling systems and intracellular regulatory pathways.

Research investigations commonly explore:

• Mitochondrial signalling peptide activity
• Mitochondrial–nuclear communication pathways
• Cellular stress response mechanisms
• Intracellular metabolic signalling networks
• Peptide-mediated regulatory processes
• Comparative mitochondrial peptide research
• Cellular regulatory pathway modelling

These experimental models allow researchers to investigate molecular signalling systems involved in mitochondrial regulation and intracellular biochemical communication.

Research Applications

In controlled research environments, Humanin may be utilised in experimental models designed to explore mitochondrial signalling systems and cellular regulatory networks.

Examples of research applications include:

• Mitochondrial signalling pathway investigation
• Cellular stress response research
• Metabolic signalling pathway analysis
• Intracellular regulatory network modelling
• Comparative peptide signalling research
• Cell signalling pathway studies
• Controlled in vitro mitochondrial biology studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.3 percent purity confirmed by COA
• Assay content verified at 10.44 mg
• Endotoxins below 0.01 EU per mg
• No detectable heavy metals or microbial contamination
• Mitochondria-derived signalling research peptide
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.